Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.

Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, Atsuta Y, Mori T; Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Oct 13. pii: S1083-8791(19)30660-3. doi: 10.1016/j.bbmt.2019.10.004. [Epub ahead of print]

PMID:
31618688
2.

Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.

Shinohara A, Oshima K, Fuji S, Umeda K, Kako S, Kurokawa M, Tsukada N, Kasai M, Kondo T, Hashii Y, Nakamae H, Ikegame K, Kosaka Y, Shimada A, Nawa Y, Makoto Y, Yoshiko A, Fukuda T, Tanaka J, Ogata M.

Biol Blood Marrow Transplant. 2019 Sep 5. pii: S1083-8791(19)30561-0. doi: 10.1016/j.bbmt.2019.08.021. [Epub ahead of print]

PMID:
31494230
3.

Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation.

Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, Ichinohe T, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Aug 7. pii: S1083-8791(19)30514-2. doi: 10.1016/j.bbmt.2019.07.042. [Epub ahead of print]

PMID:
31400501
4.

Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry.

Kondo E, Shimizu-Koresawa R, Chihara D, Mizuta S, Izutsu K, Ikegame K, Uchida N, Fukuda T, Ichinohe T, Atsuta Y, Suzuki R; Adult Lymphoma Working Group of the JSHCT.

Br J Haematol. 2019 Sep;186(6):e219-e223. doi: 10.1111/bjh.16115. Epub 2019 Jul 29. No abstract available.

PMID:
31355916
5.

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, Iijima H, Ohnishi S, Hashimoto D, Isoe T, Teshima T, Ogawa H, Sato N, Fujimori Y.

BMJ Open. 2019 Jul 9;9(7):e026403. doi: 10.1136/bmjopen-2018-026403.

6.

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0542-0. [Epub ahead of print] No abstract available.

PMID:
31089273
7.

Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1730-1743. doi: 10.1016/j.bbmt.2019.04.025. Epub 2019 May 2.

PMID:
31054982
8.

Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.

Yamasaki S, Aoki J, Mori J, Mizuno S, Uchida N, Ohashi K, Fukuda T, Ikegame K, Eto T, Ogawa Y, Tanaka M, Hidaka M, Iwato K, Sawa M, Ichinohe T, Kanda Y, Atsuta Y, Yanada M, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Apr 10. doi: 10.1038/s41409-019-0527-z. [Epub ahead of print] No abstract available.

PMID:
30971777
9.

Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.

Tamaki H, Ikegame K, Yoshihara S, Kaida K, Yoshihara K, Inoue T, Kato R, Nakata J, Fujioka T, Soma T, Okada M, Ogawa H.

Transpl Infect Dis. 2019 Jun;21(3):e13073. doi: 10.1111/tid.13073. Epub 2019 Apr 1.

PMID:
30875143
10.

Lateral thoracoaxillar dermal-fat flap for breast conserving surgery: the changes of the indication and long-term results.

Nakagomi H, Inoue M, Nakada H, Ohmori M, Nakayama Y, Furuya K, Watanabe H, Ikegame K, Kobayashi K.

Breast Cancer. 2019 Sep;26(5):595-601. doi: 10.1007/s12282-019-00959-2. Epub 2019 Mar 7.

PMID:
30847663
11.

Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.

Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, Ikegame K, Kanda Y, Kobayashi H, Ishikawa J, Ago H, Hirokawa M, Fukuda T, Atsuta Y, Kondo T.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1536-1543. doi: 10.1016/j.bbmt.2019.02.019. Epub 2019 Mar 1.

PMID:
30826464
12.

Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor.

Yamashita T, Ikegame K, Ito F, Kobayashi T, Nara M, Fujishima N, Anbai A, Inoue T, Kaida K, Tanaka H, Takahashi N.

Bone Marrow Transplant. 2019 Oct;54(10):1713-1716. doi: 10.1038/s41409-019-0482-8. Epub 2019 Mar 1. No abstract available.

PMID:
30824816
13.

Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.

Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1441-1449. doi: 10.1016/j.bbmt.2019.02.016. Epub 2019 Feb 20.

PMID:
30794929
14.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Sep;54(9):1489-1498. doi: 10.1038/s41409-019-0461-0. Epub 2019 Feb 4.

PMID:
30718800
15.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

16.

Fatigue, Muscle Oxygen Consumption and Blood Flow to the Skeletal Muscle After Allogeneic Hematopoietic Stem Cell Transplantation.

Morishita S, Wakasugi T, Kaida K, Itani Y, Ikegame K, Ogawa H, Domen K.

Adv Exp Med Biol. 2018;1072:293-298. doi: 10.1007/978-3-319-91287-5_47.

PMID:
30178361
17.

Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease.

Wakasugi T, Morishita S, Kaida K, Itani Y, Kodama N, Ikegame K, Ogawa H, Domen K.

Adv Exp Med Biol. 2018;1072:287-291. doi: 10.1007/978-3-319-91287-5_46.

PMID:
30178360
18.

Fat necrosis after breast-conserving oncoplastic surgery.

Nakada H, Inoue M, Furuya K, Watanabe H, Ikegame K, Nakayama Y, Ohmori M, Nakagomi H.

Breast Cancer. 2019 Jan;26(1):125-130. doi: 10.1007/s12282-018-0901-5. Epub 2018 Aug 27.

PMID:
30151780
19.

Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation.

Morishita S, Wakasugi T, Tanaka T, Harada T, Kaida K, Ikegame K, Ogawa H, Domen K.

Support Care Cancer. 2018 Sep;26(9):3217-3223. doi: 10.1007/s00520-018-4168-3. Epub 2018 Apr 6.

PMID:
29626261
20.

Impaired skeletal muscle oxygenation following allogeneic hematopoietic stem cell transplantation is associated with exercise capacity.

Wakasugi T, Morishita S, Kaida K, Itani Y, Kodama N, Ikegame K, Ogawa H, Domen K.

Support Care Cancer. 2018 Jul;26(7):2149-2160. doi: 10.1007/s00520-017-4036-6. Epub 2018 Jan 25.

PMID:
29372395
21.

Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.

Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihana K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y.

Bone Marrow Transplant. 2018 Apr;53(4):478-482. doi: 10.1038/s41409-017-0028-x. Epub 2018 Jan 12. No abstract available.

PMID:
29330394
22.

A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.

Okada M, Tasaka T, Ikegame K, Aotsuka N, Kobayashi T, Najima Y, Matsuhashi Y, Wada H, Tokunaga H, Masuda S, Utsu Y, Yoshihara S, Kaida K, Daimon T, Ogawa H.

Eur J Haematol. 2018 Apr;100(4):335-343. doi: 10.1111/ejh.12999. Epub 2018 Jan 17.

PMID:
29168236
23.

Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, Fukuda T, Ozawa Y, Uchida N, Iwato K, Sakura T, Hidaka M, Hashimoto H, Ichinohe T, Atsuta Y, Kanda Y.

Bone Marrow Transplant. 2017 Oct;52(10):1390-1398. doi: 10.1038/bmt.2017.153. Epub 2017 Jul 17.

PMID:
28714944
24.

Periaortitis induced by epirubicin and cyclophosphamide for a patient with advanced breast cancer.

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, Yamamoto A, Takano A, Miyasaka Y, Yasutome M, Hada M, Omata M.

Int Cancer Conf J. 2017 Jul 11;6(4):180-183. doi: 10.1007/s13691-017-0302-1. eCollection 2017 Oct.

25.

Pseudomyxoma peritonei due to low-grade appendiceal mucinous neoplasm with symptoms of inguinal hernia and uterine prolapse: a case report and review of the literature.

Watanabe H, Miyasaka Y, Watanabe K, Sakamoto I, Nakagomi H, Takano A, Ikegame K, Yamamoto A, Nakada H, Yasutome M, Furuya K, Hada M, Inoue M, Oyama T.

Int Cancer Conf J. 2017 May 13;6(4):158-163. doi: 10.1007/s13691-017-0297-7. eCollection 2017 Oct.

26.

Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation.

Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K.

Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12669. Epub 2017 Feb 21.

PMID:
28220548
27.

Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.

Yamashita T, Ikegame K, Kojima H, Tanaka H, Kaida K, Inoue T, Ogawa H.

Bone Marrow Transplant. 2017 May;52(5):794-796. doi: 10.1038/bmt.2017.10. Epub 2017 Feb 6. No abstract available.

PMID:
28165448
28.

Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, Omata M, Oyama T.

Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20.

PMID:
28108967
29.

Spousal hematopoietic stem cell transplantation.

Ikegame K, Kaida K, Yoshihara S, Yoshihara K, Ishii S, Inoue T, Okada M, Tamaki H, Soma T, Kusunoki Y, Kojima H, Saji H, Ogawa H.

Int J Hematol. 2017 May;105(5):646-657. doi: 10.1007/s12185-016-2168-y. Epub 2016 Dec 24.

PMID:
28013483
30.

Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.

Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T.

Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21.

PMID:
27869808
31.

Biliary cancer developed after the reparative surgery for congenital choledochal cyst: a case report and review of the literature.

Ikegame K, Takano A, Watanabe H, Yamamoto A, Miyasaka Y, Furuya K, Nakada H, Sugai H, Yasutome M, Inoue M, Hada M, Nakagomi H, Omata M, Oyama T.

Int Cancer Conf J. 2016 Nov 12;6(2):43-49. doi: 10.1007/s13691-016-0270-x. eCollection 2017 Apr.

32.

Report of a case with gallbladder carcinoma: P53 expression of the peritumor epithelium might predict biliary tract recurrence.

Takano A, Nakagomi H, Ikegame K, Yamamoto A, Watanabe H, Nakada H, Inoue M, Sugai H, Yasutome M, Furuya K, Hada M, Miyasaka Y, Oyama T, Omata M.

Int J Surg Case Rep. 2016;28:325-329. doi: 10.1016/j.ijscr.2016.10.042. Epub 2016 Oct 18.

33.

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group.

Haematologica. 2016 Dec;101(12):1592-1602. Epub 2016 Aug 4.

34.

Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes.

Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2031-2037. doi: 10.1016/j.bbmt.2016.07.020. Epub 2016 Aug 1.

35.

Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.

Ikegame K, Imai K, Yamashita M, Hoshino A, Kanegane H, Morio T, Kaida K, Inoue T, Soma T, Tamaki H, Okada M, Ogawa H.

J Hematol Oncol. 2016 Feb 13;9:9. doi: 10.1186/s13045-016-0240-y.

36.

Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period.

Inoue T, Ikegame K, Kaida K, Okada M, Yoshihara S, Tamaki H, Fujimori Y, Soma T, Ogawa H.

J Immunol. 2016 Jan 1;196(1):469-83. doi: 10.4049/jimmunol.1402950. Epub 2015 Nov 30.

37.

Balance function in patients who had undergone allogeneic hematopoietic stem cell transplantation.

Morishita S, Kaida K, Aoki O, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K.

Gait Posture. 2015 Sep;42(3):406-8. doi: 10.1016/j.gaitpost.2015.07.011. Epub 2015 Jul 21.

PMID:
26233580
38.

Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.

Kato R, Tamaki H, Ikegame K, Yoshihara S, Kaida K, Taniguchi K, Inoue T, Ishii S, Nakata J, Fujioka T, Eguchi R, Soma T, Okada M, Ogawa H.

Ann Hematol. 2015 Oct;94(10):1707-15. doi: 10.1007/s00277-015-2446-4. Epub 2015 Jul 22.

PMID:
26193851
39.

Pharmacokinetics of 8 mg/kg anti-human T-lymphocyte rabbit immunoglobulin conditioning for hematopoietic stem cell transplantation in Japanese patients.

Kaida K, Ikegame K, Suzuki H, Shibayama Y, Ogawa H.

Rinsho Ketsueki. 2015 May;56(5):475-80. doi: 10.11406/rinketsu.56.475. Japanese.

PMID:
26062668
40.

Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan.

Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, Ueda Y, Kaida K, Ishii S, Taniguchi K, Okada M, Tamaki H, Okumura H, Kaya H, Kurokawa T, Kodera Y, Taniguchi S, Kanda Y, Ogawa H.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1495-505. doi: 10.1016/j.bbmt.2015.04.012. Epub 2015 Apr 25.

41.

Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.

Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Kodama N, Ogawa H, Domen K.

Eur J Oncol Nurs. 2015 Oct;19(5):443-50. doi: 10.1016/j.ejon.2015.02.002. Epub 2015 Apr 21.

PMID:
25911269
42.

[Current and future status of haploidentical hematopoietic stem cell transplantation].

Ikegame K, Ogawa H.

Rinsho Ketsueki. 2015 Mar;56(3):289-97. doi: 10.11406/rinketsu.56.289. Review. Japanese.

PMID:
25876782
43.

A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.

Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2015 Jul;90(7):618-23. doi: 10.1002/ajh.24028.

44.

Risk analysis of falls in patients undergoing allogeneic hematopoietic stem cell transplantation.

Ueki S, Ikegame K, Kozawa M, Miyamoto J, Mori R, Ogawa H.

Clin J Oncol Nurs. 2014 Aug;18(4):396-9. doi: 10.1188/14.CJON.396-399.

PMID:
25095291
45.

Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT.

Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2014 Sep;49(9):1187-92. doi: 10.1038/bmt.2014.141. Epub 2014 Jul 7.

PMID:
25000457
46.

Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.

Kaida K, Ikegame K, Ikemoto J, Murata R, Irie R, Yoshihara S, Ishii S, Okada M, Inoue T, Tamaki H, Soma T, Fujimori Y, Kai S, Ogawa H.

Int J Hematol. 2014 Apr;99(4):463-70. doi: 10.1007/s12185-014-1542-x. Epub 2014 Mar 6.

PMID:
24599414
47.

Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.

Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y; Japan Society for Hematopoietic Cell Transplantation.

Ann Oncol. 2014 Feb;25(2):435-41. doi: 10.1093/annonc/mdt558. Epub 2014 Jan 7.

PMID:
24399081
48.

Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J.

Bone Marrow Transplant. 2013 Nov;48(12):1513-8. doi: 10.1038/bmt.2013.140. Epub 2013 Sep 23. Erratum in: Bone Marrow Transplant. 2013 Nov;48(12):1587.

PMID:
24056740
49.

Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine.

Kawakami M, Taniguchi K, Yoshihara S, Ishii S, Kaida K, Ikegame K, Okada M, Watanabe S, Nishina T, Hamada H, Nakagawa M, Ogawa H.

Am J Hematol. 2013 Oct;88(10):853-7. doi: 10.1002/ajh.23502. Epub 2013 Jul 23.

50.

Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.

Nakasone H, Kurosawa S, Yakushijin K, Taniguchi S, Murata M, Ikegame K, Kobayashi T, Eto T, Miyamura K, Sakamaki H, Morishima Y, Nagamura T, Suzuki R, Fukuda T.

Am J Hematol. 2013 Jun;88(6):477-84. doi: 10.1002/ajh.23436. Epub 2013 May 13.

Supplemental Content

Loading ...
Support Center